<DOC>
	<DOCNO>NCT01853592</DOCNO>
	<brief_summary>Background : - Magnetic resonance imaging ( MRI ) type image study use magnetic field radio wave take picture body . To help image show clearly , contrast agent inject vein . Researchers interested find contrast agent help show problem blood vessel around heart . They want test agent call Gadofosveset Trisodium see work MRI scan . Objectives : - To test effectiveness Gadofosveset Trisodium contrast agent heart MRI scan . Eligibility : - Healthy volunteer 18 45 year age . Design : - Participants screen physical exam medical history . They provide blood sample scan session . - Participants MRI scan screen visit . They dose contrast scan study . - Participants return one additional MRI scan within 1 2 month scan . Different dos contrast agent use scan . - An additional blood sample collect within 1 week second MRI scan .</brief_summary>
	<brief_title>Gadofosveset Trisodium Heart Imaging Studies</brief_title>
	<detailed_description>The purpose study determine diagnostic quality contrast-enhanced coronary magnetic resonance angiography ( MRA ) improve use high versus lower dose gadolinium-based contrast agent . We compare two dos intravascular contrast agent ( Gadofosveset , 0.03 0.06 mmol/kg ) pilot dose study . Healthy participant recruit clinical indication MR angiography safety clearance IV gadolinium contrast MR scanning . Subjects evaluate order determine signal noise ratio ( SNR ) contrast noise ratio ( CNR ) coronary artery increase high dose contrast agent . Parameters compare pair t-testing significance .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<criteria>INCLUSION CRITERIA : A . Able understand sign inform consent . B . Able complete MRI scan . C. Age 1845 year old . D. eGFR great equal 60mL/min/1.73m ( 2 ) within 1 week prior gadolinium injection . E. NIH employee may involve NIH requirement follow laid NIH Policy Manual 23006303 Leave Policy NIH Employees Participating NIH Medical Research Studies . F. Willing travel NIH schedule followup visit scan well potential repeat scan event suboptimal scanning . EXCLUSION CRITERIA : Individuals exclude study : A. Contraindications undergo MRA Please review Radiology MRI section MRI safety questionnaire . B. MRI contrast within last 6 month ( selfreported ) outside protocol . C. Contra indication receive gadoliniumbased contrast agent ( specify MRI safety questionnaire ) : 1 . Allergy gadoliniumbased contrast 2 . Labs : i. Kidney liver function upper limit normal ii . eGFR &lt; 60ml/min/1.73m ( 2 ) iii . Pregnancy test : positive c. Acute renal failure , renal transplantation , curent dialysis treatment hepatorenal syndrome d. History liver transplantation severe liver disease e. Severe Asthma f. Hemoglobinopathies g. History multiple myeloma h. History significant allergic reaction gadoliniumbased contrast agent i. Evaluated increased risk Nephrogenic Systemic Fibrosis ( NSF ) . D. Current write ( selfreported ) record : 1. atrial fibrillation 2. cardiac surgery 3. cancer treatment 4. comorbid condition otherwise indicate participant renal function may deteriorate study procedure due participant underlie medical condition would allow study subject complete protocol . E. Current write ( selfreported ) record active : 1 . Clinically diagnosed angina , heart failure , and/or clinically significant electrical conduction abnormality heart . 2 . Pregnancy lactation 3 . Mental , neurologic social condition prevent understanding rationale , procedure , risk potential benefit associate trial 4 . Paralyzed hemidiaphragm 5 . Over 400 lbs and/or body circumference prevents adequate MRI gantry insertion . 6 . Unable lay flat scanner 7 . Claustrophobia otherwise require anesthesia sedation undergo MRI . 8 . Participant able undergo intravenous line placement and/or refuse gadolinium contrast . F. Any condition precludes safety MRI per researcher evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 13, 2016</verification_date>
	<keyword>Gadolinium Contrast</keyword>
	<keyword>Cardiac MRI</keyword>
	<keyword>MRA</keyword>
	<keyword>MRI</keyword>
	<keyword>MRI Safety</keyword>
</DOC>